Types of Cancer We Treat

Pancreatic Cancer

We combine evidence-based medicine with compassionate, personalized care to diagnose and treat people with pancreatic cancer. Our team of specialists is at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

At our Pancreatic Cancer Center, we create an individualized treatment plan for you, drawing on our expertise in endoscopic and surgical treatments as well as medical therapies.

Meet Our Doctors
Dr. Diane Simeone
Our Approach to Treating Pancreatic Cancer Our Approach to Pancreatic Cancer Treatment
Diagnosis
Diagnosing Pancreatic Cancer
Surgery
Surgery for Pancreatic Cancer
Chemotherapy & Targeted Drugs
Chemotherapy & Targeted Drugs for Pancreatic Cancer
Radiation Therapy
Radiation Therapy for Pancreatic Cancer

Related News

Early Detection Can Improve Survival for Pancreatic Cancer
Read Story
Pancreatic Cancer Can Be Detected Early
Read Story
Pancreatic Cancer Forum Hosted on Long Island
Read Story
An Ambitious Research Strategy to Fight Pancreatic Cancer
Read Story
Researchers Unlock New Insights to Pancreatic Cancer
Read Story
Expert Discusses Advances in Pancreatic Cancer Treatment
Read Story
Turning Discoveries into Medicine
Read Story
Combating Pancreatic Cancer by Starving Tumor Cells
Read Story
Immune Receptor Helps Gut Microbes Fuel Pancreatic Cancer
Read Story

Clinical Trials and Research Studies

Phase 1/2

A Phase 1/2 Study of Oral LOXO-292 in Patients With Advanced Solid Tumors Including RET Fusion-Positive Solid Tumors Medullary Thyroid Cancer and Other Tumors With RET Activation (LIBRETTO-001)

Learn More

Phase 3

A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic Adenocarcinoma of the Pancreas

Learn More

Phase 3

PANOVA-3: Pivotal randomized open-label study of Tumor Treating Fields (TTFields 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma

Learn More

Phase 1

A phase I open-label dose-escalation study to investigate the safety pharmacokinetics pharmacodynamics and clinical activity of GSK3368715 in participants with solid tumors and DLBCL

Learn More
View All Related Clinical Trials (11)